Article Details

Sequoia-backed Chinese heart valve developer Venus Medtech gets funding from DCP Capital

Retrieved on: 2018-05-16 08:45:00

Tags for this article:

Click the tags to see associated articles and topics

Sequoia-backed Chinese heart valve developer Venus Medtech gets funding from DCP Capital. View article details on hiswai:

Excerpt

<div>The company, which is backed by Sequoia China, Goldman Sachs, and <b>Qiming</b> <b>Venture Partners</b>, now has more than 300 patents of valve technology ...</div>

Article found on:

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up